News from dipexium pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 22, 2016, 04:39 ET Dipexium and PLx Pharma Announce Merger Agreement

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) and PLx Pharma Inc. (PLx Pharma), a privately held late-stage specialty pharmaceutical company,...

Nov 10, 2016, 07:00 ET Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

Oct 25, 2016, 07:00 ET Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex® in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle Plus Standardized Wound Care

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) ("Dipexium" or the "Company") today announced that the OneStep-1 and OneStep-2 Phase 3 clinical trials...

Oct 20, 2016, 07:00 ET Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX) ("Dipexium" or the "Company"), a late-stage pharmaceutical company focused on the development and...

Oct 04, 2016, 08:00 ET Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX) ("Dipexium" or the "Company"), a late-stage pharmaceutical company focused on the development and...

Sep 07, 2016, 10:56 ET Dipexium Pharmaceuticals annonce la délivrance d'un brevet pour le Locilex® par l'Union européenne

Dipexium Pharmaceuticals, Inc. (Nasdaq : DPRX), société pharmaceutique de stade avancé axée sur le développement et la commercialisation du Locilex®...

Sep 07, 2016, 08:00 ET Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

Sep 07, 2016, 02:13 ET Dipexium Pharmaceuticals kündigt Patenterteilung für Locilex® durch die Europäische Union an

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), ein Late-Stage-Pharmaunternehmen mit Schwerpunkt auf der Entwicklung und Kommerzialisierung von...

Aug 24, 2016, 08:00 ET Dipexium Pharmaceuticals Announces Participation in September Investor Conferences

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

Aug 04, 2016, 07:00 ET Dipexium Pharmaceuticals Reports Second Quarter 2016 Financial Results

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

Jul 28, 2016, 07:00 ET Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) will release its financial results for the quarter ended June 30, 2016, on Thursday, August 4, 2016 at...

Jun 20, 2016, 04:01 ET Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

May 16, 2016, 08:22 ET Dipexium gibt Erreichung des Aufnahmeziels für die klinische OneStep-1-Pivot-Studie der Phase 3 bekannt

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), ein Unternehmen für Arzneimittel im fortgeschrittenen Entwicklungsstadium, das sich auf die...

May 16, 2016, 08:10 ET Dipexium annonce avoir atteint ses objectifs de recrutement dans l'étude clinique pivot de phase 3 OneStep-1

Dipexium Pharmaceuticals, Inc. (Nasdaq : DPRX), une société pharmaceutique de stade avancé axée sur le développement et la commercialisation de...

May 16, 2016, 08:00 ET Dipexium Announces Completion of Enrollment Objective in OneStep-1 Pivotal Phase 3 Clinical Trial

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

May 12, 2016, 07:00 ET Dipexium Pharmaceuticals Announces Completion of Enrollment Objective in OneStep-2 Pivotal Phase 3 Clinical Trial and First Quarter 2016 Financial Results

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

May 09, 2016, 08:00 ET Dipexium Pharmaceuticals to Hold First Quarter 2016 Financial Results Conference Call on Thursday, May 12, 2016, at 8:30 a.m. ET

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) will release its financial results for the quarter ended March 31, 2016, on Thursday, May 12, 2016 at...

Mar 28, 2016, 08:00 ET Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent in Japan

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

Mar 23, 2016, 07:00 ET Dipexium Pharmaceuticals Reports 2015 Financial Results

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

Mar 14, 2016, 07:00 ET Dipexium Pharmaceuticals to Hold Year End 2015 Financial Results Conference Call on Wednesday, March 23, 2016, 8:30 a.m. ET

Dipexium Pharmaceuticals (NASDAQ: DPRX) will release its financial results for the year ended December 31, 2015, on Wednesday, March 23, 2016 at...

Mar 02, 2016, 08:00 ET Dipexium Pharmaceuticals Announces Presentation at Raymond James 37th Annual Institutional Investors Conference

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex®...

Feb 04, 2016, 08:00 ET Dipexium Pharmaceuticals Reaches 75% Enrollment Milestone in Pivotal Phase 3 Clinical Trials

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

Feb 01, 2016, 08:00 ET Dipexium Pharmaceuticals Announces Issuance of Locilex® Patents in Australia and New Zealand

Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of Locilex®...

Jan 29, 2016, 08:00 ET Dipexium Pharmaceuticals Announces Presentation at 18th Annual BIO CEO & Investor Conference

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex®...

Jan 06, 2016, 07:00 ET Dipexium Pharmaceuticals Announces Presentation at Biotech Showcase™ 2016

Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex®...